Mouse organic cation transporter 1 determines properties and regulation of basolateral organic cation transport in renal proximal tubules

Pflugers Archiv European Journal of Physiology

Volumn 466, Issue 8, 2014, Pages 1581-1589

  Schlatter, Eberhard ^a   Klassen, Philipp ^a   Massmann, Vivian ^a   Holle, Svenja K ^a   Guckel, Denise ^a   Edemir, Bayram ^a   Pavenstädt, Hermann ^a   Ciarimboli, Giuliano ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Epithelial transport; Microdissection; Microfluorimetry; mOCT1 2 knockout; mOCT2 knockout; Protein kinase; Regulation; Substrate specificity

Indexed keywords

CALMODULIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 3; PHOSPHATIDYLINOSITOL 3 KINASE; ORGANIC CATION TRANSPORTER; SLC22A2 PROTEIN, HUMAN; SLC22A2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOLATERAL MEMBRANE; CATION TRANSPORT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; KIDNEY; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; WILD TYPE; ACTIVE TRANSPORT; ANIMAL; ENZYME SPECIFICITY; HEK293 CELL LINE; ION TRANSPORT; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; FEMALE; HEK293 CELLS; HUMANS; ION TRANSPORT; KIDNEY TUBULES, PROXIMAL; MALE; MICE; MICE, KNOCKOUT; ORGANIC CATION TRANSPORT PROTEINS; ORGANIC CATION TRANSPORTER 1; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUBSTRATE SPECIFICITY;

EID: 84904252639     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-013-1395-9     Document Type: Article

References (45)

1. Alnouti Y, Petrick JS, Klaassen CD (2006) Tissue distribution and ontogeny of organic cation transporters in mice. Drug Metab Dispos 34:477-482 (Pubitemid 43290907)
2. Aoki M, Terada T, Kajiwara M, Ogasawara K, Ikai I, Ogawa A, Katsura M, Inui D (2008) Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation. Am J Physiol Renal Physiol 295(1):F165-F170
3. Arndt P, Volk C, Gorboulev V, Budiman T, Popp C, Ulzheimer-Teuber I, Akhoundova A, Koppatz S, Bamberg E, Nagel G, Koepsell H (2001) Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1. Am J Physiol Renal Physiol 281:F454-F468
4. Cetinkaya I, Ciarimboli G, Yalcinkaya G, Mehrens T, Velic A, Hirsch JR, Gorboulev V, Koepsell H, Schlatter E (2003) Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases. Am J Physiol Renal Physiol 284:F293-F302 (Pubitemid 36114692)
5. Chen R, Jonker JW, Nelson JA (2002) Renal organic cation and nucleoside transport. Biochem Pharmacol 64:185-190 (Pubitemid 34775297)
6. Ciarimboli G (2008) Organic cation transporters. Xenobiotica 38:936-971
7. Ciarimboli G (2011) Role of organic cation transporters in drug-induced toxicity. Expert Opin Drug Metab Toxicol 7:159-174
8. Ciarimboli G, Deuster D, Knief A, Sperling M, Holtkamp M, Edemir B, Pavenstädt H, Lanvers-Kaminsky C, am Zehnhoff-Dinnesen A, Schinkel AH, Koepsell H, Jürgens H, Schlatter E (2010) Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions. Am J Path 176(3):1169-1180
9. Ciarimboli G, Holle SK, Vollenbröker B, Hagos Y, Reuter S, Burckhardt G, Bierer S, Herrmann E, Pavenstädt H, Rossi R, Kleta R, Schlatter E (2011) New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2. Mol Pharm 8:270-279
10. Ciarimboli G, Koepsell H, Iordanova M, Gorboulev V, Dürner B, Lang D, Edemir B, Schröter R, Van Le T, Schlatter E (2005) Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation. J Am Soc Nephrol 16:1562-1570 (Pubitemid 41716463)
11. Ciarimboli G, Lancaster CS, Schlatter E, Franke RM, Sprowl JA, Pavenstädt H, Massmann V, Guckel D, Mathijssen RH, Yang W, Pui CH, Relling MV, Herrmann E, Sparreboom A (2012) Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients. Clin Cancer Res 18:1101-1108
12. Ciarimboli G, Ludwig T, Lang D, Pavenstädt H, Koepsell H, Piechota H-J, Haier J, Jaehde U, Zisowsky J, Schlatter E (2005) Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. Am J Path 167:1477-1484 (Pubitemid 41713303)
13. Ciarimboli G, Schlatter E (2005) Regulation of organic cation transport. Pflugers Arch 449:423-441 (Pubitemid 40238877)
14. Ciarimboli G, Schröter R, Neugebauer U, Vollenbröker B, Gabriels G, Brzica H, Sabolic I, Pietig G, Pavenstädt H, Schlatter E, Edemir B (2013) Kidney transplantation down-regulates expression of organic cation transporters, which translocate beta-blockers and fluoroquinolones. Mol Pharm 10:2370-2380
15. Ciarimboli G, Struwe K, Arndt P, Gorboulev V, Koepsell H, Schlatter E, Hirsch JR (2004) Regulation of the human organic cation transporter hOCT1. J Cell Physiol 201:420-428 (Pubitemid 39456441)
16. Dresser MJ, Gray AT, Giacomini KM (2000) Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1). J Pharmacol Exp Ther 292(3):1146-1152 (Pubitemid 30136612)
17. Eisner C, Faulhaber-Walter R, Wang Y, Leelahavanichkul A, Yuen PST, Mizel D, Star RA, Briggs JP, Levine M, Schnermann J (2010) Major contribution of tubular secretion to creatinine clearance in mice. Kidney Int. doi:10.1038/ki2009.501
18. Green RM, Lo K, Sterritt C, Beier DR (1999) Cloning and functional expression of a mouse liver organic cation transporter. Hepatology 29:1556-1562 (Pubitemid 29211060)
19. Guckel D, Ciarimboli G, Pavenstädt H, Schlatter E (2012) Regulation of organic cation transport in isolated mouse proximal tubules involves complex changes in protein trafficking and substrate affinity. Cell Physiol Biochem 30:269-281
20. Higgins JW, Bedwell DW, Zamek-Gliszczynski MJ (2012) Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics. Drug Metab Dispos 40:1170-1177
21. Hohage H, Mörth DM, Querl IU, Greven J (1994) Regulation by protein kinase C of the contraluminal transport system for organic cations in rabbit kidney S2 proximal tubules. J Pharmacol Exp Ther 268:897-901 (Pubitemid 24085891)
22. Holle SK, Ciarimboli G, Edemir B, Neugebauer U, Pavenstädt H, Schlatter E (2011) Properties and regulation of organic cation transport in freshly isolated mouse proximal tubules analyzed with a fluorescence reader-based method. Pflugers Arch 462:359-369
23. Ito S, Kusuhara H, Yokochi M, Toyoshima J, Inoue K, Yuasa H, Sugiyama Y (2012) Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney. J Pharmacol Exp Ther 340:393-403
24. Jonker JW, Schinkel AH (2004) Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharmacol Exp Ther 308:2-9 (Pubitemid 38090693)
25. Jonker JW, Wagenaar E, Van Eijl S, Schinkel AH (2003) Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/ Slc22a2]) in mice abolishes renal secretion of organic cations. Mol Cell Biol 23:7902-7908 (Pubitemid 37271485)
26. Kakehi M, Koyabu N, Nakamura T, Uchiumi T, Kuwano M, Ohtani H, Sawada Y (2002) Functional characterization of mouse cation transporter mOCT2 compared with mOCT1. Biochem Biophys Res Commun 296:644-650
27. Koepsell H (1998) Organic cation transporters in intestine, kidney, liver, and brain. Annu Rev Physiol 60:243-266
28. Koepsell H (2004) Polyspecific organic cation transporters: their functions and interactions with drugs. Trends Pharmacol Sci 25:375-381
29. Koepsell H (2013) The SLC22 family with transporters of organic cations, anions and zwitterions. Mol Aspects Med 34:413-435
30. Koepsell H, Busch AE, Gorboulev V, Arndt P (1998) Structure and function of renal organic cation transporters. News Physiol Sci 13:11-16
31. Koepsell H, Endou H (2004) The SLC22 drug transporter family. Pflugers Arch 447:666-676 (Pubitemid 38241452)
32. Koepsell H, Gorboulev V, Arndt P (1999) Molecular pharmacology of organic cation transporters in kidney. J Membr Biol 167:103-117 (Pubitemid 29061900)
33. Koepsell H, Schmitt BM, Gorboulev V (2003) Organic cation transporters. Rev Physiol Biochem Pharmacol 150:36-90
34. Lee WK, Reichold M, Edemir B, Ciarimboli G,Warth R, Koepsell H, Thevenod F (2009) Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule. Am J Physiol Renal Physiol 296:F1504-F1513
35. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408 (Pubitemid 34164012)
36. Massmann V, Edemir B, Schlatter E, Al-Monajjed R, Harrach S, Klassen P, Holle SK, Sindic A, Dobrivojevic M, Pavenstädt H, Ciarimboli G (2013) The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3. Pflügers Arch. doi:10.1007/s00424-013-1335-8
37. Mehrens T, Lelleck S, Çetinkaya I, Knollmann M, Hohage H, Gorboulev V, Bokník P, Koepsell H, Schlatter E (2000) The affinity of the organic cation transporter rOCT1 is increased by protein kinase C dependent phosphorylation. J Am Soc Nephrol 11:1216-1224 (Pubitemid 30416217)
38. Pietig G,Mehrens T, Hirsch JR, Cetinkaya I, Piechota H, Schlatter E (2001) Properties and regulation of organic cation transport in freshly isolated human proximal tubules. J Biol Chem 276:33741-33746
39. Schaeffeler E, Hellerbrand C, Nies AT, Winter S, Kruck S, Hofmann U, van der Kuip H, Koepsell H, Schwab M (2011) DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma. Genome Med 3(12):82
40. Schafer JA, Watkins ML, Li L, Herter P, Haxelmans S, Schlatter E (1997) A simplified method for isolation of large numbers of defined nephron segments. Am J Physiol Renal Physiol 273:F650-F657
41. Schmitt A, Mössner R, Gossmann A, Fischer IG, Gorboulev V, Murphy DL, Koepsell H, Lesch KP (2003) Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice. J Neurosci Res 71:701-709 (Pubitemid 36255354)
42. Tang SC, Hendrikx JJ, Beijnen JH, Schinkel AH (2013) Genetically modified mouse models for oral drug absorption and disposition. Curr Opin Pharmacol 13:1-6
43. Vialou V, Amphoux A, Zwart R, Giros B, Gautron S (2004) Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci 24:2846-2851 (Pubitemid 38380963)
44. Wilde S, Schlatter E, Koepsell H, Edemir B, Reuter S, Pavenstädt H, Neugebauer U, Schröter R, Brast S, Ciarimboli G (2009) Calmodulin- associated post-translational regulation of rat organic cation transporter 2 in the kidney is gender dependent. Cell Mol Life Sci 66:1729-1740
45. Yacovino LL, Aleksunes LM (2012) Endocrine and metabolic regulation of renal drug transporters. J Biochem Mol Toxicol 26(10):407-421